Michael Kelly

Michael Kelly has extensive work experience in the pharmaceutical industry, beginning in 1991 with TAP Pharmaceuticals as a Regional Manager, Hospital and Managed Care. Michael then moved to ViroPharma Incorporated in 1997, where they held the roles of Vice President, Sales and Vice President, Marketing. In 2002, they joined Guilford Pharmaceuticals as Vice President, Commercial Operations. In 2005, they moved to Azur Pharma, Inc. as SVP, General Manager US Operations. Michael then joined Jazz Pharmaceuticals in 2012 as SVP, Sales and Marketing. In 2013, they became President and Chief Executive Officer of Covis Pharmaceuticals, Inc. and in 2016, they were appointed President, US Operations of Adapt Pharma. Most recently, in 2019, they were appointed Director of ARS Pharmaceuticals, Inc.

Michael Kelly earned their MBA from Rider University in 1991 and their BS in Business from The College of New Jersey in 1987.